LAGUNA HILLS, Calif., May 23, 2018 – /Globe Newswire/ – Sonendo, Inc., developers of the GentleWave® Procedure, a breakthrough alternative to standard root canal treatment, will attend the 2018 Stifel Dental & Veterinary Conference. The conference will take place in New York City on Wednesday, May 30th. Bjarne Bergheim, Sonendo’s President and CEO is scheduled to present at 2:25 PM.
“I am looking forward to this year’s conference,” Mr. Bergheim said. “In April we participated in the AAE 2018 Annual Event, and it was a resounding success for Sonendo. We also recently surpassed a significant commercial milestone by shipping more than fifty-thousand GentleWave® Procedure Instruments to our customers in the United States. I look forward to sharing more information about our commercial journey at this year’s conference.”
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science®. The first commercially available product from Sonendo, the GentleWave System, available in the US, shows significant improvements in clinical efficacy and treatment efficiency when compared to standard root canal techniques.1,2
1 Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2 Molina B et al. (2015) J Endod. 41:1701-05.
This announcement contains forward-looking statements based on management's beliefs, assumptions and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.